Other New Drugs
Other New Drugs
- Gilead Sciences, Tibotec to Develop Second Once-Daily HIV Treatment (July 17, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Acyclovir: The Next New HIV Drug? (February 10, 2009)
From Project Inform
- High-Dose Intravenous Immunoglobulin May Reduce Latent HIV Reservoir in Resting CD4+ Cells, Study Suggests (February 10, 2009)
A five-day course of high-dose intravenous immunoglobulin appears to somehow activate replication-competent HIV in the resting CD4+ cells of patients on HAART, ultimately leading to a reduction in those patients' latent HIV reservoirs, according to the results of a nine-patient study presented by Magnus Gisslén, M.D., Ph.D.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- The Next Generation of Boosters: Promising Data on Potential Alternatives to Ritonavir (February 9, 2009)
Brian Kearney, Pharm.D., of Gilead Sciences Inc., and Robert Guttendorf, Ph.D., of Sequoia Pharmaceuticals discuss encouraging findings from early human trials on a pair of pharmacokinetic enhancers whose utility could potentially extend far beyond protease inhibitor boosting.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Biotechnology Company to Launch Trial of New HIV/AIDS Treatment That Would Target DNA (February 4, 2009)
The treatment involves taking a sample of an HIV-person's CD4 cells and disrupting the CCR5 gene, which is the molecule HIV usually attaches to before infecting the cell. The idea is that, when those modified CD4 cells are put back into an HIVer's body, they'll multiply into an HIV-resistant army of immune cells.
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Gilead Aiming to Put Four HIV Drugs in One Pill (January 14, 2009)
From aidsmap.com
- Step Aside, Atripla? New Four-in-One Pill to Enter Development (January 12, 2009)
From Bloomberg.com
- Experimental Treatment Lengthens Lifespan of Monkeys With Simian Version of HIV, Study Says (December 12, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Existing Anti-Obesity Drugs May Be Effective Against Flu, Hepatitis and HIV (September 29, 2008)
From University of Rochester Medical Center
- Major Setback for Experimental Therapeutic HIV Vaccine (July 10, 2008)
In aidsmap.com
- Suppression of Human Protein Reduces HIV's Ability to Enter T Cells, Replicate, Study Finds (April 30, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- New Kind of Antiretroviral, KP-1461, Clinical Trial Recruiting; Interview With Stephen Becker, M.D. (October 11, 2007)
In AIDS Treatment News, from AIDS Treatment News
- Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says (April 20, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Australia: Biotron Anti-HIV Compound, Virion, Shown to Act Against HIV (August 23, 2005)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Gilead's Fixed-Dose Combination of Truvada + Efavirenz Not Yet Bioequivalent to Drugs Alone (August 10, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- New Vulnerability Found in AIDS Virus, German Scientists Say (August 3, 2005)
[Archived Article]
In vitro tests find that a peptide appears to halt HIV assembly.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Tat Inhibitors, a New Approach: Interview With Olaf Kutsch, Ph.D. (February 28, 2005)
[Archived Article]
Years ago, a Tat inhibitor worked well in the lab but failed in patients; modern biotechnology, however, may give the drug new life.
In AIDS Treatment News, from AIDS Treatment News
- Behind the December 2004 "AIDS Breakthrough" Headlines (December 31, 2004)
[Archived Article]
Mid-December press reports were exaggerated, but still important; they focus on DAPYs, a promising new family of HIV meds.
In AIDS Treatment News, from AIDS Treatment News
- Statins May Help Treat HIV (October 2004)
[Archived Article]
Quick recap of a recent study on Mevacor in the Journal of Experimental Medicine.
To read PDF, click here
In HIV Treatment ALERTS!, from The Center for AIDS
- Treatment of HIV Infection With Prednisolone (July 13, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO
- Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Scientists Find HIV-Blocking Protein in Monkeys (February 25, 2004)
[Archived Article]
TRIM5-alpha is the first host protein found that specifically targets HIV's capsid.
From U.S. National Institute of Allergy and Infectious Diseases
- Novel Agents Show Promise as Anti-HIV Compounds (December 30, 2003)
[Archived Article]
Pyridine oxide derivatives may not only prevent HIV replication, they may prevent the virus from reactivating as well.
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Capsid Protein Assembly Inhibitors: Potential New Class of Antiviral Drugs (May 7, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Discovery Lays Groundwork for Potential New Class of Anti-HIV Drugs (March 31, 2003)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Digging Deeper at the Resistance Workshop (August 14, 2002)
[Archived Article]
Key clinical findings from July's XI International HIV Drug Resistance Workshop.
From International AIDS Society
- New Cancer Drugs Might Help Treat HIV -- But Research Not Done (April 12, 2002)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- HE2000: An Immune System Regulator (February 2002)
[Archived Article]
In Reasons for Hope, from Search for a Cure
- New Immune-Based Treatment Approach: Trial Recruiting in San Francisco (February 23, 2001)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- HE2000 Begins Clinical Trials: Interview With James Frincke, Ph.D. (June 4, 1999)
[Archived Article]
From AIDS Treatment News
- New Antiviral Substances Found With HCG (March 19, 1999)
[Archived Article]
From AIDS Treatment News
- RU-486 (Spring 1999)
[Archived Article]
In Notes From the Underground, from PWA Health Group
- Immunologic Parameters Modified in HIV Disease by the Drug WF10 (a Phase II Pathogenesis Study) (February 2, 1999)
[Archived Article]
In The 6th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
|
|
Advertisement
|
E-Mail
Glossary
Share
